Document Type
A3
Publication Date
10-8-2018
Institution/Department
Center for Performance Improvement
Abstract
Decrease in Cervidil use for cervical ripening by 20% of anticipated doses prior to Dec 1, 2018 (6 mos) , with a potential for cost savings = 40 doses x approx. $2000/dose = $80,000.
Recommended Citation
Sepulveda, Deb; Pinette, Michael G.; Morin, Heidi; Dumais, Colette; Austin, Sarah; Tarraza, Hector; Tkacz, Maria; and Abbott, Zander, "Cervical Ripening for Induction of Labor" (2018). Maine Medical Center. 552.
https://knowledgeconnection.mainehealth.org/mmc/552
COinS
